09/25/2023 ADOCIA Announces Oral Presentations on AdoShell® Islets at EASD and IPITA-IXA-CTRMS Congresses Icon check
09/18/2023 ADOCIA Announces First Half 2023 Financial Results and Provides a Business Update Icon check
09/14/2023 Number of shares and voting rights of ADOCIA as of August 31st, 2023 Icon check
08/31/2023 ADOCIA Announces that it has Received €500.000 in Proceeds from a Partial Exercise of Warrants Held by IPF Partners Icon check
07/25/2023 ADOCIA announces Q2 2023 financial results and a €10 million financing operation Icon check
07/05/2023 ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing Icon check
06/01/2023 Listing of ADOCIA shares suspended Icon check
05/15/2023 ADOCIA Announces the Appointment of Olivier Soula as Chief Executive Officer Icon check
04/25/2023 ADOCIA Reports Financial Results of First Quarter 2023 and Provides an Update on its Activities Icon check
04/20/2023 ADOCIA announces its annual Shareholders’ meeting to be held on May 11, 2023 in Paris Icon check
03/15/2023 ADOCIA announces its annual results for 2022 and provides corporate and financial update Icon check
01/30/2023 ADOCIA publishes its Letter to Shareholders Icon check
12/21/2022 ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2023 Icon check
12/01/2022 Adocia strengthens its cash position with EUR 6 million through the issuance of convertible bonds subscribed by European investors in order to accelerate the development of key products Icon check
10/25/2022 ADOCIA Reports its Cash Position and Revenue for the Third Quarter of 2022 and Provides Business Updates Icon check
10/06/2022 ADOCIA Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes using M1Pram in a post-hoc analysis Icon check
10/03/2022 ADOCIA: Upcoming investor meetings Icon check
09/19/2022 ADOCIA Announces First Half 2022 Financial Results and Provides a Business Update Icon check
09/15/2022 ADOCIA Will Release its 2022 Half-Year Results on September 19th and Hold a Webinar on September 20th Icon check
09/07/2022 ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell® Islets for the Treatment of Type 1 Diabetes Icon check
08/24/2022 ADOCIA Reports Cash and Revenue for the Second Quarter and Provides Corporate Update Icon check
06/23/2022 Adocia publishes its Letter to Shareholders Icon check
06/21/2022 ADOCIA announces M1Pram Phase 2 Trial Meets Primary Objective by Reducing Weight in Overweight People with Type 1 Diabetes Icon check
05/20/2022 ADOCIA Announces its annual Shareholders’ meeting to be held on June 28, 2022 in Paris Icon check
05/18/2022 ADOCIA Announces The First Subject Treated In BioChaperone® Combo Clinical Studies with Partner Tonghua Dongbao Icon check
05/09/2022 ADOCIA Announces the First Patient Dosed In the BioChaperone® Lispro Phase 3 Program with Partner Tonghua Dongbao Icon check
04/19/2022 ADOCIA announces its annual results for 2021 and presents an update on activities Icon check
04/11/2022 ADOCIA Announces Start of 3 Clinical Studies for BioChaperone® Combo with Partner Tonghua Dongbao Icon check
03/28/2022 Adocia strengthens its cash position by 19 million euros following a real estate transaction Icon check
02/23/2022 ADOCIA announces 2021 fourth quarter financial results Icon check
01/11/2022 Number of shares and voting rights of ADOCIA as of December 31st, 2021 Icon check
01/06/2022 ADOCIA announces its financial calendar for 2022 Icon check
12/20/2021 ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2022 Icon check
12/13/2021 Adocia Files Patent for Technology to Enable Oral Drug Delivery of Peptides Icon check
10/26/2021 Adocia announces 2021 third quarter financial results and a financing of €7 million Icon check
10/14/2021 ADOCIA’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial in China Icon check
09/21/2021 ADOCIA announces Oral Presentation Reviewing M1Pram (ADO09) at the occasion of the 57th Annual Meeting of EASD Icon check
09/10/2021 Adocia To Participate in the H.C. Wainwright 23rd Annual Global Investment Conference Icon check
09/07/2021 ADOCIA Announces First Half 2021 Financial Results and Provides an Update on Activities Icon check
08/23/2021 Number of shares and voting rights of ADOCIA as of July 31st, 2021 Icon check
07/22/2021 ADOCIA Announces Second Quarter 2021 Financial Results Icon check
06/29/2021 ADOCIA Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes Icon check
06/15/2021 ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81st Scientific Sessions Icon check
06/08/2021 ADOCIA confirms its eligibility for the PEA–PME Icon check
06/02/2021 ADOCIA Presents Clinical Results on M1Pram at the 14th International Conference on ATTD 2021 Icon check
06/01/2021 ADOCIA reinforces its board of directors with the appointment of three new independent members. Icon check
05/26/2021 ADOCIA Expands Clinical Development to Obesity with Patent Applications on Short-Acting Multihormonal Combinations Administered by Pumps Icon check
05/11/2021 ADOCIA Announces the Live Broadcast of its Annual General Meeting on May 20th, 2021 Icon check
04/21/2021 ADOCIA Announces the Release of its Universal Registration Document for the Year 2020 Icon check
04/21/2021 ADOCIA Announces First Quarter 2021 Financial Results Icon check
03/18/2021 ADOCIA Announces Financial Results 2020 And Provides Corporate Update. Icon check
03/10/2021 Adocia Initiates Phase 2 Clinical Trial for M1Pram in Patients with Type 1 Diabetes Icon check
01/25/2021 Adocia Announces Positive Clinical Results Confirming the Ultra-Rapid Profile of a BioChaperone® Lispro Formulation Containing Insulin from Partner Tonghua Dongbao
01/11/2021 Adocia Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabetes Icon check
12/21/2020 Adocia announces its financial calendar for 2021 Icon check
10/20/2020 Adocia Announces Third Quarter 2020 Financial Results Icon check
09/22/2020 Adocia announces a Video Conference to Present a Corporate Update Wednesday, September 23rd, 2020 Icon check
09/15/2020 Adocia announces Positive Topline Results of Phase 1b Study for M1Pram in People with type 1 Diabetes. Icon check
09/07/2020 September 15th: Adocia to Present at H.C. Wainwright Global Investment Conference (Virtual Event) Icon check
09/03/2020 September 10th: Adocia Oral Presentation at the Annual Congress of the Société Francophone du Diabète (SFD). Icon check